Cowen analyst Chris Shibutani raised the price target on Array BioPharma (NASDAQ: ARRY) to $23.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View Analyst PT Change

Array BioPharma (ARRY) PT Raised to $29 at StifelFebruary 5, 2019 3:55 PM Array BioPharma (ARRY) PT Raised to $24 at JefferiesFebruary 5, 2019 1:47 PM Array Biopharma (ARRY) call put ratio 11 calls to 1 put with focus on February 20 callsFebruary 5, 2019 12:43 PM Array BioPharma (ARRY) PT Raised to $34 at GuggenheimFebruary 5, 2019 11:57 AM Form 10-Q ARRAY BIOPHARMA INC For: Dec 31February 5, 2019 8:09 AM Form 8-K ARRAY BIOPHARMA INC For: Feb 05February 5, 2019 8:04 AM Array Biopharma (ARRY) Tops Q2 EPS by 10c, Revenues BeatFebruary 5, 2019 8:02 AM Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2019February 5, 2019 8:00 AM